Black Rock Inc. Novo Cure LTD Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Black Rock Inc. holds 12,132,397 shares of NVCR stock, worth $374 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,132,397
Previous 9,084,412
33.55%
Holding current value
$374 Million
Previous $142 Million
46.37%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Vanguard Group Inc Valley Forge, PA11.8MShares$365 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$244 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$133 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$93.3 Million12.67% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$86.4 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.23B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...